Gangly Flamingo is a podcast for the alcohol-free community about pushing through the awkwardness of rediscovering ourselves without booze. Visit www.GanglyFlamingo.com for more information and ways to connect.
In this episode, creator and host, Mark Schulz, introduces a third episode type for the show: a 15-20 minute news program format covering recent events and research findings relates to Alcohol Use Disorder (AUD) and/or anxiety. This episode format will join the guest interviews and the guided meditation formats already available. Reach out and share your feedback!
Episode References
- Cheong, JeeWon, and Jalie A. Tucker. “Utility of Interactive Voice Response Self-Monitoring in Stabilizing Initial Change during Natural Recovery Attempts among Persons with Alcohol Use Disorder.” Journal of Substance Abuse Treatment, vol. 140, Sept. 2022, p. 108831. EBSCOhost, https://doi.org/10.1016/j.jsat.2022.108831.
- Wilens, Timothy E., et al. “The Impact of Pharmacotherapy of Childhood-Onset Psychiatric Disorders on the Development of Substance Use Disorders.” Journal of Child and Adolescent Psychopharmacology, vol. 32, no. 4, May 2022, pp. 200–14. EBSCOhost, https://doi.org/10.1089/cap.2022.0016.
- Krewson, Celest. “Pharmacological treatments found effective against substance use disorders.” Contemporary Pediatrics, August 10, 2022. https://www.contemporarypediatrics.com/view/pharmacological-treatments-found-effective-against-substance-use-disorders
- Jaasma, Michael. (2019 May 20 - 2020 March 26). Pilot Evaluation of the Empower Neuromodulation System in AUD Patients. Identifier NCT03983317. https://clinicaltrials.gov/ct2/show/study/NCT03983317
- Empower Neuromodulation System, a home-use device for the treatment of anxiety disorders. https://www.sbir.gov/node/2189423
Enjoying Gangly Flamingo? Help us spread the word! Share on Twitter Share on Facebook
To stay up to date on all things Gangly, subscriber to the weekly newsletter.
No materials produced by Gangly Flamingo should be treated as professional medical advice. See full legal disclaimers here